$ 177.17
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA,...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair value on
Target Price
The average target price of JNJ is 172 and suggests 3% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to decrea
